Long-term cure of a non-small-cell lung cancer treated by monochemotherapy

Am J Clin Oncol. 1996 Jun;19(3):260-2. doi: 10.1097/00000421-199606000-00010.

Abstract

Cure after 8 years of a non-small-cell lung cancer (NSCLC), inoperable because of locoregional spread, is reported. The authors believe this case represents the longest survival after monochemotherapy reported to date and provides the opportunity to review studies of prognostic factors concerning long-term survival in NSCLC.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / mortality
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality
  • Male
  • Middle Aged
  • Vinblastine / analogs & derivatives*
  • Vinblastine / therapeutic use
  • Vinorelbine

Substances

  • Antineoplastic Agents, Phytogenic
  • Vinblastine
  • Vinorelbine